Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Combinatorial strategies for the induction of immunogenic cell death

L. Bezu, LC. Gomes-de-Silva, H. Dewitte, K. Breckpot, J. Fucikova, R. Spisek, L. Galluzzi, O. Kepp, G. Kroemer,

. 2015 ; 6 (-) : 187.

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc15023708

The term "immunogenic cell death" (ICD) is commonly employed to indicate a peculiar instance of regulated cell death (RCD) that engages the adaptive arm of the immune system. The inoculation of cancer cells undergoing ICD into immunocompetent animals elicits a specific immune response associated with the establishment of immunological memory. Only a few agents are intrinsically endowed with the ability to trigger ICD. These include a few chemotherapeutics that are routinely employed in the clinic, like doxorubicin, mitoxantrone, oxaliplatin, and cyclophosphamide, as well as some agents that have not yet been approved for use in humans. Accumulating clinical data indicate that the activation of adaptive immune responses against dying cancer cells is associated with improved disease outcome in patients affected by various neoplasms. Thus, novel therapeutic regimens that trigger ICD are urgently awaited. Here, we discuss current combinatorial approaches to convert otherwise non-immunogenic instances of RCD into bona fide ICD.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15023708
003      
CZ-PrNML
005      
20150729104312.0
007      
ta
008      
150709s2015 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2015.00187 $2 doi
035    __
$a (PubMed)25964783
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Bezu, Lucillia $u Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Metabolomics and Cell Biology Platforms, Gustave Roussy Campus Cancer , Villejuif , France ; Faculté de Medecine, Université Paris-Sud , Le Kremlin-Bicêtre , France.
245    10
$a Combinatorial strategies for the induction of immunogenic cell death / $c L. Bezu, LC. Gomes-de-Silva, H. Dewitte, K. Breckpot, J. Fucikova, R. Spisek, L. Galluzzi, O. Kepp, G. Kroemer,
520    9_
$a The term "immunogenic cell death" (ICD) is commonly employed to indicate a peculiar instance of regulated cell death (RCD) that engages the adaptive arm of the immune system. The inoculation of cancer cells undergoing ICD into immunocompetent animals elicits a specific immune response associated with the establishment of immunological memory. Only a few agents are intrinsically endowed with the ability to trigger ICD. These include a few chemotherapeutics that are routinely employed in the clinic, like doxorubicin, mitoxantrone, oxaliplatin, and cyclophosphamide, as well as some agents that have not yet been approved for use in humans. Accumulating clinical data indicate that the activation of adaptive immune responses against dying cancer cells is associated with improved disease outcome in patients affected by various neoplasms. Thus, novel therapeutic regimens that trigger ICD are urgently awaited. Here, we discuss current combinatorial approaches to convert otherwise non-immunogenic instances of RCD into bona fide ICD.
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Gomes-de-Silva, Ligia C $u Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Metabolomics and Cell Biology Platforms, Gustave Roussy Campus Cancer , Villejuif , France ; Department of Chemistry, University of Coimbra , Coimbra , Portugal.
700    1_
$a Dewitte, Heleen $u Laboratory for General Biochemistry and Physical Pharmacy, Faculty of Pharmacy, Ghent University , Ghent , Belgium ; Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel , Jette , Belgium.
700    1_
$a Breckpot, Karine $u Laboratory of Molecular and Cellular Therapy, Vrije Universiteit Brussel , Jette , Belgium.
700    1_
$a Fucikova, Jitka $u Sotio a.c. , Prague , Czech Republic ; Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles University , Prague , Czech Republic.
700    1_
$a Spisek, Radek $u Sotio a.c. , Prague , Czech Republic ; Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles University , Prague , Czech Republic.
700    1_
$a Galluzzi, Lorenzo $u Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Gustave Roussy Campus Cancer , Villejuif , France ; Université Paris Descartes , Paris , France ; Université Pierre et Marie Curie , Paris , France.
700    1_
$a Kepp, Oliver $u Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Metabolomics and Cell Biology Platforms, Gustave Roussy Campus Cancer , Villejuif , France.
700    1_
$a Kroemer, Guido $u Equipe 11 labellisée par la Ligue Nationale contre le Cancer, Centre de Recherche des Cordeliers , Paris , France ; U1138, INSERM , Paris , France ; Metabolomics and Cell Biology Platforms, Gustave Roussy Campus Cancer , Villejuif , France ; Department of Immunology, 2nd Faculty of Medicine, University Hospital Motol, Charles University , Prague , Czech Republic ; Université Paris Descartes , Paris , France ; Université Pierre et Marie Curie , Paris , France ; Pôle de Biologie, Hopitâl Européen George Pompidou, AP-HP , Paris , France.
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 6, č. - (2015), s. 187
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25964783 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150709 $b ABA008
991    __
$a 20150729104358 $b ABA008
999    __
$a ind $b bmc $g 1084040 $s 906701
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 6 $c - $d 187 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20150709

Najít záznam

Citační ukazatele

Možnosti archivace